YAP1 as a Novel Negative Biomarker of Immune Checkpoint Inhibitors for EGFR-Mutant Non-Small-Cell Lung Cancer

YAP1 as a Novel Negative Biomarker of Immune Checkpoint Inhibitors for EGFR-Mutant Non-Small-Cell Lung Cancer

Background. Immune checkpoint inhibitors (ICIs) have become a standard care in non-small-cell lung cancer (NSCLC). However, its application to epidermal growth factor receptor (EGFR)-mutant NSCLC patients is confronted with drug resistance. This study aimed to clarify the potential role of Yes1-asso...

Full description

Saved in:
Bibliographic Details
Main Authors: Ling-Chen Li, Xie-Wan Chen, Ling Fang, Chun-Li Jian, Yong-Xin Yu, Xing-Yun Liao, Jian-Guo Sun
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Canadian Respiratory Journal
Online Access:http://dx.doi.org/10.1155/2023/4689004
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items